Key result
Higher doses of norepinephrine to a target MAP of 90 mm Hg improved RV free wall peak strain from -19% to -25% (P=0.003) in septic shock patients, without affecting RV afterload.
Why the study?
The study evaluated the effects of norepinephrine-induced changes in MAP on RV systolic function, afterload, and pulmonary haemodynamics in septic shock, hypothesising RV systolic function improves at higher MAP levels.
Does higher dose norepinephrine (target MAP 90 mmHg) improve right ventricular systolic function in patients with septic shock?
Observational (n=11)
random sequential order
Does higher dose norepinephrine (target MAP 90 mmHg) improve right ventricular systolic function in patients with septic shock?
Absolute Event Rate: -25% vs -19%
p-value: p=.003
In patients with septic shock, titrating norepinephrine to a higher MAP target of 90 mmHg improves right ventricular systolic function without adversely affecting right ventricular afterload.
May support higher MAP targets to improve RV function in septic shock; hypothesis-generating and requires randomized confirmation.
Background In this observational study, the effects of norepinephrine‐induced changes in mean arterial pressure (MAP) on right ventricular (RV) systolic function, afterload and pulmonary haemodynamics were studied in septic shock patients. We hypothesised that RV systolic function improves at higher doses of norepinephrine/MAP levels. Methods Eleven patients with septic shock requiring norepinephrine after fluid resuscitation were included <24 hours after ICU arrival. Study enrolment and insertion of a pulmonary artery catheter was performed after written informed consent from the next of kin. Norepinephrine infusion was titrated to target mean arterial pressures (MAP) of 60, 75 and 90 mmHg in a random sequential order. At each target MAP, strain—and conventional echocardiographic—and pulmonary haemodynamic variables were measured. RV afterload was assessed as effective pulmonary arterial elastance, ( E pa ) and pulmonary vascular resistance index, (PVRI). RV free wall peak strain was the primary end‐point. Results At highest compared to lowest norepinephrine dose/MAP level, RV free wall peak strain increased from −19% to −25% (32%, P = .003), accompanied by increased tricuspid annular plane systolic excursion (22%, P = .01). At the highest norepinephrine dose/MAP, RV end‐diastolic area index (16%, P < .001), central venous pressure (38%, P < .001), stroke volume index (7%, P = .001), mean pulmonary artery pressure (19%, P < .001) and RV stroke work index (15%, P = .045) increased, with no effects on PVRI or E pa . Cardiac index did not change, assessed by thermodilution ( P = .079) and echocardiography ( P = .054). Conclusions Higher doses of norepinephrine to a target MAP of 90 mm Hg improved RV systolic function while RV afterload was not affected.
No takes yet. Share an insight, caveat, or question.
Dalla et al. (2019) conducted an observational in septic shock (n=11). Norepinephrine vs. lowest norepinephrine dose/MAP level was evaluated on RV free wall peak strain (p=.003). Higher doses of norepinephrine to a target MAP of 90 mm Hg improved RV free wall peak strain from -19% to -25% (P=0.003) in septic shock patients, without affecting RV afterload.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: